Skip to main content
Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time
Alerts Watchlist Portfolio

Today's Trading

Day Low 39.81
Day High 40.45
Open:39.89
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Latest
investment ideas
After blazing energy rally, investors check the fuel gauge
Subscriber content
world
Britain approves Pfizer and BioNtech COVID-19 vaccine; expects to roll out immunization program next week
report on business
Inside Acuitas Therapeutics, the Vancouver company providing a crucial piece of Pfizer’s COVID-19 vaccine
Subscriber content
inside the market
Market movers: Stocks that saw action on Wednesday - and why
Subscriber content
inside the market
What every Canadian investor needs to know today
Subscriber content
world
EU drug agency eyes Dec. 29 approval for first COVID-19 vaccine
Description
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

View Earnings zacks

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy
View Estimates zacks

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDF Refinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDF StockCalc

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Download Free PDF ValueEngine logo

Latest Press Releases

More Stories
Thinking about trading options or stock in Norwegian Cruise Line, Pfizer, General Electric, Walt Disney, or Intel Corp?
- PR Newswire - PRF - Fri Dec 4, 8:31AM CST
PR Newswire - PRF - CMTX
Fri Dec 4, 8:31AM CST
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NCLH, PFE, GE, DIS, and INTC.
Thinking about trading options or stock in Norwegian Cruise Line, Pfizer, General Electric, Walt Disney, or Intel Corp?
- PR Newswire - Fri Dec 4, 8:31AM CST
PR Newswire - PRNW
Fri Dec 4, 8:31AM CST
NEW YORK , Dec. 4, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NCLH, PFE, GE, DIS, and INTC.
Ocular Inflammation Treatment Market Research 2020: Global Size, Growth, Trends, Outlook and Future Scope Analysis
- Heraldkeepers - Fri Dec 4, 2:29AM CST
Heraldkeepers - CMTX
Fri Dec 4, 2:29AM CST
The is expected to exceed more than US$ 500 Billion by 2024 at a CAGR of 6% in the given forecast period.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 35.82 +12.53% increase
on 11/17/20
Period Open:37.33
Price movement based on the high, low and last over the given period.
41.99 -4.00% decrease
on 11/09/20
 +2.98 (+7.98%) increase
since 11/04/20
3-Month 34.60 +16.50% increase
on 10/29/20
Period Open:36.36
Price movement based on the high, low and last over the given period.
41.99 -4.00% decrease
on 11/09/20
 +3.95 (+10.86%) increase
since 09/04/20
52-Week 27.88 +44.58% increase
on 03/23/20
Period Open:38.14
Price movement based on the high, low and last over the given period.
41.99 -4.00% decrease
on 11/09/20
 +2.17 (+5.69%) increase
since 12/04/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies